<DOC>
	<DOCNO>NCT01930539</DOCNO>
	<brief_summary>This randomize , control , unblinded pilot study patient vitamin D deficiency Intestinal Rehabilitation clinic . These patient able absorb oral vitamin D efficiently thus high prevalence vitamin D deficiency , lead low bone density . The investigator use FDA approve portable Ultraviolet B lamp intervention group , 70 patient recruit October 2013 end January 2014 study period 12 week patient . Study completion end April 2014 . Study hypothesis : Ultraviolet B light portable UV device increase Total 25 hydroxy vitamin D level Intestinal Rehabilitation Clinic patient .</brief_summary>
	<brief_title>Treatment Vitamin D Deficiency Intestinal Rehabilitation Clinic Patients With Portable Ultraviolet B Lamp</brief_title>
	<detailed_description>Vitamin D play integral role bone metabolism one principal hormonal regulator calcium phosphorus absorption body . In 2011 , Endocrine Society define Vitamin D deficiency 25 hydroxy vitamin D 20 ng/ml vitamin D insufficiency 25 hydroxy vitamin D 21 ng/ml 29 ng/ml.Without vitamin D , 10 15 % dietary calcium 60 % phosphorus absorb . Intestinal Rehabilitation clinic University Nebraska Medical Center include patient short bowel syndrome , multiple abdominal fistula , alter GI motility . Hypovitaminosis D associate increase parathyroid hormone secretion , increase bone turnover , osteoporosis , histological osteomalacia increase risk hip fracture , , severe expression , clinical osteomalacia . These patient give high dos oral vitamin D2 vitamin D3 supplementation without improvement vitamin D status due poor intestinal absorption . Standardized treatment vitamin D deficiency healthy individual achieve give vitamin D2 50,000 IU week week daily supplementation lower dos . In investigator Intestinal rehabilitation clinic , patient vitamin D insufficient deficient large replacement dos vitamin D2/D3 take 200,000 IU daily . It report irradiation Ultraviolet B use safely effectively treat vitamin D deficiency among vitamin D deficient patient . Exposure body bath suit 1 Minimum Erythemal Dose ( MED ) sunlight equivalent ingest 10,000 IU 25,000 IU vitamin D. Thus , exposure 6 % 10 % body surface 1 MED equivalent ingest 600 2500 IU vitamin D. Although ultraviolet irradiation achieve exposure sunlight , generally available seasonally difficult person ill spend much time outdoors . Ultraviolet-Fluorescent lamp ( KBD , Inc , Crescent Springs , Kentucky , USA ) design use ultraviolet B emit fluorescent bulb low heat emission allow large area skin exposure . The Lamp equip timer improved safety . This device FDA ( Food Drug Administration ) approve . Baseline labs include 25 hydroxy D , intact parathyroid hormone complete metabolic profile . Patients receive 3 minute skin exposure Ultraviolet B light develop sun burn , randomize Control Ultraviolet B light group . Patients continue current dose Vitamin D2/D3 12 week groups.Ultraviolet B light administer 3 different area day 5 minute , week distance 14 inch wear UV eye shield . Areas skin exposure base rule nine body surface area include back , abdomen , thigh , arm . Patients get blood draw every 4 week monitor response Ultraviolet B light . If Ultraviolet B light able increase total 25 hydroxy vitamin D level , potentially use home patient receive basic training instruction .</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Short Bowel Syndrome</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>25hydroxy vitamin D level 15ng/ml 30mg/ml Age 19 year Patients stable dose vitamin D2/D3 last 3 month Hypercalcemia ( Serum Calcium ( calculate ) 1 mg/dl upper limit normal i.e 11.3 mg/dl ) Symptomatic Hypocalcemia ( describe tetany ) History Sarcoidosis Granulomatous diseases Patients Calcitriol Liver failure define bilirubin 3 , International Normalized Ratio 3 , Hepatic Transaminases 3 time upper limit normal , Decompensated cirrhosis sign icterus , varix , portal hypertension , encephalopathy . History transplant undergoing transplant evaluation Planned Elective surgery 6 month Personal Family history skin cancer History photosensitivity Active skin disease area plan Ultraviolet B exposure Medications limit sunlight exposure ( tetracyclines fluoroquinolones ) Patients already undergo tan session Patients plan pregnancy breastfeed Subjects fair skin type I ( Always burn easily , never tan )</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>